Provided by Tiger Trade Technology Pte. Ltd.

Bluejay Diagnostics Inc

0.9000
-0.0095-1.04%
Post-market: 0.8925-0.0075-0.83%19:59 EDT
Volume:11.37M
Turnover:12.00M
Market Cap:4.02M
PE:-0.14
High:1.24
Open:0.9200
Low:0.8843
Close:0.9095
52wk High:16.68
52wk Low:0.8300
Shares:4.47M
Float Shares:4.38M
Volume Ratio:102.07
T/O Rate:259.82%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-6.6477
EPS(LYR):-15.2513
ROE:-98.89%
ROA:-51.08%
PB:0.43
PE(LYR):-0.06

Loading ...

Company Profile

Company Name:
Bluejay Diagnostics Inc
Exchange:
NASDAQ
Establishment Date:
2015
Employees:
- -
Office Location:
360 Massachusetts Avenue,Suite 203,Acton,Massachusetts,United States
Zip Code:
01720
Fax:
- -
Introduction:
Bluejay Diagnostics, Inc. operates as a medical diagnostics company. The company offers Symphony platform, a technology platform comprising Symphony analyzer that orchestrates whole blood processing, biomarker isolation, and immunoassay preparation using non-contact centrifugal force; and Symphony Cartridge, which includes reagents and components. It also provides ALLEREYE diagnostic test, a point-of-care device for the diagnosis of allergic conjunctivitis. In addition, the company develops Symphony IL-6 test for the monitoring of disease progression in critical care settings. Further, it develops cardiac biomarkers, such as hsTNT and NT pro-BNP, as well as other tests using the Symphony platform. The company was incorporated in 2015 and is headquartered in Acton, Massachusetts.

Directors

Name
Position
Donald R. Chase
Chairman of the Board and Director
Neil Dey
Chief Executive officer and Director and President and Principal Financial and Accounting Officer
Douglas C. Wurth
Director
Fred S. Zeidman
Director
Svetlana Dey
Director

Shareholders

Name
Position
Neil Dey
Chief Executive officer and Director and President and Principal Financial and Accounting Officer